Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Antiviral Res. 2022 Mar 13;200:105291. doi: 10.1016/j.antiviral.2022.105291

Table 1.

IC50 values of each compounds on inhibition of various orthomyxovirus MG activities (μM)

hDHODH-IN-4 Brequinar Favipiravir Sofosbuvir
IAV MG 0.32 0.12 196.23 >200
Bat IAV MG 0.22 0.07 108.71 >200
IDV MG 0.23 0.05 92.67 >200
THOV MG 0.12 0.04 111.66 >200
BRBV MG 0.33 0.07 64.48 >200